Skip to main content
H.R. 5185 House Government Operations and Politics

To make improvements in the enactment of title 41, United States Code, into a positive law title and to improve the Code.

House Floor, still live
Introduced
Sep 8, 2025
Sponsor
Rep. Kamlager-Dove, Sydney (D-CA-37)
View on Congress.gov (opens in a new tab)

STAGE 4 OF 8 — HOUSE FLOOR

Currently in the House. Last action: received in the senate and read twice and referred to the committee on the judiciary on Sep 14, 2026.

  1. House Introduced in House Sep 8, 2025
  2. House Referred to the House Committee on the Judiciary. Sep 8, 2025
  3. House Committee Consideration and Mark-up Session Held Sep 10, 2025
  4. House Ordered to be Reported by Voice Vote. Sep 10, 2025
  5. House Considered under suspension of the rules. (consideration: CR H5304-5319) Aug 31, 2026
  6. House On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5304-5319) Aug 31, 2026
  7. House Mr. Schmidt moved to suspend the rules and pass the bill. Aug 31, 2026
  8. House Considered under suspension of the rules. Aug 31, 2026
  9. House DEBATE - The House proceeded with forty minutes of debate on H.R. 5185. Aug 31, 2026
  10. House Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. Aug 31, 2026
  11. House On motion to suspend the rules and pass the bill Agreed to by voice vote. Aug 31, 2026
  12. House Motion to reconsider laid on the table Agreed to without objection. Aug 31, 2026
  13. Senate Received in the Senate and Read twice and referred to the Committee on the Judiciary. Sep 14, 2026

Subjects

Public contracts and procurement

Committees

  • Judiciary Committee
    • [Referred To, Sep 14, 2026]
  • Judiciary Committee
    • [Markup By, Sep 10, 2025]
    • [Referred To, Sep 8, 2025]

Summary

This bill makes technical and conforming changes to the U.S. Code that are related to the enactment of Title 41 (Public Contracts) into positive law.

[Summary as of: Introduced in House]

Comments · 0

Loading...

Loading comments...